Home | MyCME | All CME | Blog | Psychlopedia
Multimedia CME
Multimedia | CME From JCP | JCP Supplement | CME From PCC

MultimediaAfter so many years of having inadequate treatment options, you can finally offer patients with tardive dyskinesia approved medications that reduce symptoms. Follow along as expert Dr Leslie Citrome reviews the evidence. [top]

Revisiting Tardive Dyskinesia: Focusing on the Basics of Identification and Treatment

Medication Options and Clinical Strategies for Treating Tardive Dyskinesia

Leslie L. Citrome, MD, MPH

Identifying Tardive Dyskinesia: Risk Factors, Functional Impact, and Diagnostic Tools

Stephen R. Saklad, PharmD, BCPP

Strategies for Acute and Maintenance Treatment of Bipolar I Disorder

Strategies for Shifting From Acute to Maintenance Treatment for Bipolar I Disorder

Trisha Suppes, MD, PhD

Evidence-Based Treatment Targets, Selection, and Strategies for Acute Manic and Mixed Episodes of Bipolar I Disorder

Trisha Suppes, MD, PhD

Earlier Diagnosis and Expanded Treatment Options for Patients With Parkinson Disease

Effective Treatment Strategies for Motor and Nonmotor Symptoms of Parkinson Disease

Stuart H. Isaacson, MD

Early Recognition and Diagnosis of Parkinson Disease and Ongoing Assessments

Stuart H. Isaacson, MD

Early Recognition and Treatment of Tardive Dyskinesia in Patients with Mood Disorders and Schizophrenia

Treatment Strategies for Tardive Dyskinesia

Daniel E. Kremens, MD, JD

Earlier Diagnosis of Tardive Dyskinesia

Daniel E. Kremens, MD, JD

FDA-Approved Medications to Treat Tardive Dyskinesia

Joseph P. McEvoy, MD

Psychosocial Implications of Tardive Dyskinesia in Patients With Mood Disorders Versus Schizophrenia

Joseph P. McEvoy, MD

A Multidisciplinary Approach for Addressing Challenges in Alzheimer’s Disease

A Multidisciplinary Approach for Addressing Challenges in Alzheimer's Disease

Alireza Atri, MD, PhD; Simon Sheard, DO; and Danielle Goldfarb, MD

Cognitive Assessment of Alzheimer’s Disease and Dementias in Clinical Practice: Pragmatics of Brief Instruments and Neuropsychological Evaluation

Lynn Shaughnessy, PsyD; Simon Sheard, DO; Danielle Goldfarb, MD; and Alireza Atri, MD, PhD

Disclosure of Alzheimer’s Disease and Dementia: Patient- and Care Partner-Centric Decision-Making and Communication

Danielle Goldfarb, MD; Simon Sheard, DO; Lynn Shaughnessy, PsyD; and Alireza Atri, MD, PhD

New Mechanisms, New Opportunities: Integrating Novel Antidepressants in the Treatment of Major Depressive Disorder

New Mechanisms, New Opportunities: Integrating Novel Antidepressants in the Treatment of Major Depressive Disorder

Leslie Citrome, MD, MPH; James W. Murrough, MD, PhD; Joseph F. Goldberg, MD; Bradley N. Gaynes, MD, MPH; and Terence Ketter, MD

Managing Transitions in Care and Adherence to Improve Outcomes in Schizophrenia

Managing Transitions in Care and Adherence to Improve Outcomes in Schizophrenia

John Lauriello, MD and Diana O. Perkins, MD

Overcoming Challenges in Diagnosis and Depression Management in Pediatric Bipolar Disorder

Treating Bipolar Disorder in Pediatric Patients and Educating Patients and Parents

Melissa P. DelBello, MD, MS

Using Screening Tools and Diagnosing Bipolar Disorder in Pediatric Patients

Manpreet K. Singh, MD, MS

Current and Emerging Treatments to Address Unmet Needs in MDD

Current and Emerging Treatments to Address Unmet Needs in MDD

Michael E. Thase, MD

Improving the Diagnosis and Treatment of Adolescent Bipolar Disorder

Diagnosing Bipolar Disorder in Pediatric Patients

Kiki D. Chang, MD

Treating Bipolar Disorder in Adolescents

Robert L. Findling, MD, MBA

Cognitive Impairment in Patients With Depression: Awareness, Assessment, and Management

Cognitive Impairment in Major Depressive Disorder: A Case Discussion Illustrating Impact, Assessment, and Management

Larry Culpepper, MD, MPH (Chair); Raymond W. Lam, MD, FRCPC; and Roger S. McIntyre, MD, FRCPC

Strategies for Managing Patients With Depression Who Are Experiencing Cognitive Impairment

Larry Culpepper, MD, MPH

Impact of Cognitive Impairment on Functioning in Patients With Depression

Raymond W. Lam, MD, FRCPC

Available Tools for Assessing Cognitive Impairment in Major Depressive Disorder

Roger S. McIntyre, MD, FRCPC

Emerging Treatment Strategies for Patients With Tardive Dyskinesia

Assessing Patients for Tardive Dyskinesia

John M. Kane, MD

Comparing Treatments for Tardive Dyskinesia

Leslie L. Citrome, MD, MPH

Epidemiology and Prevention of Tardive Dyskinesia

Christoph U. Correll, MD

​​​​